Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Farrelly

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
BMJ Open Respiratory Research|June 15, 2023
Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohortSophie Tisi, Andrew W Creamer, Jennifer Dickson, et al.
European Radiology|May 19, 2025
Incidence rate and malignancy risk in new nodules in a lung cancer screening programmeAndrew W Creamer, Carolyn Horst, Priyam Verghese, et al.
The European Respiratory Journal|July 27, 2022
Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometrySophie Tisi, Jennifer L Dickson, Carolyn Horst, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2024
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trialSiow Ming Lee, Madeleine Hewish, Samreen Ahmed, et al.
BMJ Open Respiratory Research|February 6, 2025
Uptake and 4-week outcomes of an 'opt-out' smoking cessation referral strategy in a London-based lung cancer screening settingAmyn Bhamani, Evangelos Katsampouris, Fanta Bojang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 29, 2025
Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer ScreeningEvangelos Katsampouris, Amyn Bhamani, Fanta Bojang, et al.
European Radiology|July 4, 2026
Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safeAmyn Bhamani, Chuen R Khaw, Ruth Prendecki, et al.
The Lancet. Public Health|January 28, 2023
Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort studyJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Thorax|February 2, 2026
Upstaging of screen-detected lung cancers during diagnostic assessmentMonica L Mullin, Priyam Verghese, Chuen R Khaw, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 20, 2021
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001Christian Marth, Rafal Tarnawski, Alexandra Tyulyandina, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
BMJ Open Respiratory Research|June 15, 2023
Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohortSophie Tisi, Andrew W Creamer, Jennifer Dickson, et al.
European Radiology|May 19, 2025
Incidence rate and malignancy risk in new nodules in a lung cancer screening programmeAndrew W Creamer, Carolyn Horst, Priyam Verghese, et al.
The European Respiratory Journal|July 27, 2022
Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometrySophie Tisi, Jennifer L Dickson, Carolyn Horst, et al.
European Journal of Cancer (Oxford, England : 1990)|December 18, 2024
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trialSiow Ming Lee, Madeleine Hewish, Samreen Ahmed, et al.
BMJ Open Respiratory Research|February 6, 2025
Uptake and 4-week outcomes of an 'opt-out' smoking cessation referral strategy in a London-based lung cancer screening settingAmyn Bhamani, Evangelos Katsampouris, Fanta Bojang, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 29, 2025
Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer ScreeningEvangelos Katsampouris, Amyn Bhamani, Fanta Bojang, et al.
European Radiology|July 4, 2026
Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safeAmyn Bhamani, Chuen R Khaw, Ruth Prendecki, et al.
The Lancet. Public Health|January 28, 2023
Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort studyJennifer L Dickson, Helen Hall, Carolyn Horst, et al.
Thorax|February 2, 2026
Upstaging of screen-detected lung cancers during diagnostic assessmentMonica L Mullin, Priyam Verghese, Chuen R Khaw, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 20, 2021
Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001Christian Marth, Rafal Tarnawski, Alexandra Tyulyandina, et al.
Pageof 4